Recently, GEN News ran an article by Richard Stein about some significant advances being made with RNA-seq solutions. Entitled “If ‘Overall’ Underwhelms, Try RNA-Seq,” the article covers several compelling use cases and includes commentary with scientific leaders from each area. Stein details how researchers are using RNA-seq to investigate topics that range from oncology and embryo development to co-expression and microbiome. These studies push boundaries and knowledge beyond what has previously been possible, paving the way for tangible results, including more effective therapies and a clearer understanding of how and why embryonic cells develop.
As part of this coverage, Stein writes about our suite of bioinformatics tools that support RNA-seq research. He calls out the relevance of Ingenuity® Pathway Analysis™ (IPA) and Biomedical Genomics Workbench, and mentions Jean-Noel Billaud’s recent demonstration of the RNA-seq solution at the annual meeting of the American Association for Cancer Research (AACR) in New Orleans.
We really enjoyed the article for its news-filled look at how RNA-seq and IPA combine to further science, medicine and drug discovery. We’re always interested in learning what people are doing with our solutions. If you’re using our RNA-seq solutions in new or meaningful ways, feel free to get in touch and tell us more. You’re also invited to join our 2016 Summer Scientific Excellence Contest, where you can submit a proposal on a research topic to enter and win a one-year subscription of our RNA-Seq Explorer Solution.
More information
Get more details about our RNA-Seq Explorer Solution
Learn more about Biomedical Genomics Workbench
Learn more about Ingenuity Pathway Analysis
